Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Ketamine and Risperidone on Cognition in Healthy Volunteers vs Schizophrenia
NCT01140620Phase 4Completed
- Sponsor
- The University of Manchester
- Start
- Jun 2010
- Primary completion
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of risperidone in schizophrenia (5 arms), sponsored by The University of Manchester. Primary endpoints: Biconditional learning task at 6 months, Eye movement task at 6 months and 7 more. Started Jun 2010; status: completed.
02
Drugs
risperidone
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT01140620.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01140620.